電泳市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區）：產業預測（2024-2031）

2022年全球電泳市場規模為27.7億美元，從2023年的29.3億美元成長到2031年的45.6億美元，在預測期間（2024-2031年）預計複合年成長率為5.7%。

市場洞察表明，對慢性病管理的需求不斷成長，特別是心血管疾病、癌症和個人化醫療，正在推動強勁的成長。世界衛生組織 (WHO) 預測，新增癌症患者數量將從 2022 年的 2,000 萬增加到 2050 年的 3,500 萬，從而迫切需要先進的診斷技術。電泳對於基因組學、蛋白質組學和個人化治療至關重要，產業和學術界之間的合作正在不斷加強，創新也不斷促進。這些夥伴關係關係利用最尖端科技來發現生物標記並在分子層面上了解疾病機制，從而提供針對個體遺傳特徵的治療方法。此外，先進電子系統的整合有望提高診斷和評估的準確性和效率，從而導致醫療解決方案的重大進步。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 專利分析
• 案例研究

全球電泳市場規模/複合年成長率：依產品類型分類（2024-2031）

• 市場概況
• 電泳試劑
  • 凝膠
  • 緩衝
  • 染料
  • 其他
• 電泳系統
  • 凝膠電泳系統
  • 毛細管電泳系統
  • 微晶片電泳系統
• 凝膠文件系統
• 軟體

全球電泳市場規模/複合年成長率：依應用分類（2024-2031）

• 市場概況
• 調查
  • 蛋白質體學
  • 基因組學
  • 藥物發現
• 診斷
  • 血紅素分析
  • 蛋白質分析
  • DNA 和 RNA 分析
• 品管和過程檢驗

全球電泳市場規模/複合年成長率：依最終用戶分類（2024-2031）

• 市場概況
• 學術研究所
• 製藥和生物技術公司
• 醫院/診斷中心
• 其他

全球電泳市場規模/複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2023年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Agilent Technologies, Inc.
• Danaher Corporation
• PerkinElmer, Inc.
• Merck KGaA
• QIAGEN NV
• Lonza Group Ltd.
• Harvard Bioscience, Inc.
• Takara Bio Inc.
• Promega Corporation
• Analytik Jena AG
• Sebia Group
• Cleaver Scientific Ltd.

結論和建議

Global Electrophoresis Market size was valued at USD 2.77 billion in 2022 and is poised to grow from USD 2.93 billion in 2023 to USD 4.56 billion by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031).

Market insights reveal robust growth driven by escalating demand for chronic disease management, particularly in cardiovascular diseases, cancer, and personalized medicine. With the World Health Organization projecting a staggering 35 million new cancer cases by 2050, up from 20 million in 2022, the need for advanced diagnostic techniques is urgent. Increased collaborations between academia and industry are fostering innovations in electrophoresis, crucial for genomics, proteomics, and personalized therapeutics. These partnerships leverage cutting-edge technology to uncover biomarkers and understand disease mechanisms at a molecular level, thereby tailoring therapies to individual genetic profiles. Additionally, the integration of advanced electronic systems enhances accuracy and efficiency in diagnostics and assessments, positioning the market for significant advancements in healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophoresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophoresis Market Segmental Analysis

Global Electrophoresis Market is segmented by product type, application, end user and region. Based on product type, the market is segmented into electrophoresis reagents (gels, buffers, dyes, other), electrophoresis systems (gel electrophoresis systems, capillary electrophoresis systems, microchip electrophoresis systems), gel documentation systems and software. Based on application, the market is segmented into research (proteomics, genomics, drug discovery), diagnostics (hemoglobin analysis, protein analysis, DNA & RNA analysis) and quality control & process validation. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electrophoresis Market

The global electrophoresis market is primarily driven by the growing demand for personalized medicine and enhanced diagnostic accuracy. As researchers and clinicians seek more precise diagnostic tools, the need for effective separation and analysis of biomolecules, including proteins, nucleic acids, and peptides, intensifies. Techniques such as gel electrophoresis and capillary electrophoresis are pivotal in this process, significantly influencing advancements in proteomics and genomics. As these fields continue to evolve, the reliance on electrophoretic methods propels market expansion, facilitating the development of tailored treatments and ensuring high accuracy in diagnostics, thus fostering further innovation and investment in the electrophoresis sector.

Restraints in the Global Electrophoresis Market

One significant restraint in the Global Electrophoresis market is the elevated expenses linked to equipment and consumables. These high costs can hinder widespread adoption, particularly among smaller laboratories that require sophisticated devices for precise electrophoresis analysis. While basic electrophoresis techniques can be straightforward and cost-effective, more advanced methods-such as two-dimensional gel electrophoresis (2D-GE) and capillary electrophoresis (CE)-demand both a systematic approach and higher financial investment. This financial barrier can make it challenging for smaller organizations to access and implement these advanced technologies, limiting their participation in the evolving electrophoresis landscape.

Market Trends of the Global Electrophoresis Market

The Global Electrophoresis market is witnessing a significant trend towards the integration of automation and miniaturization, reshaping its landscape. Automated systems enhance throughput and accuracy while minimizing manual intervention, appealing to high-demand laboratories and clinics. Additionally, the miniaturization of electrodes facilitates the development of portable electrophoresis systems, catering to point-of-care testing and field applications. This dual focus not only optimizes laboratory efficiencies but also resonates with the growing need for cost-effective and versatile solutions in the healthcare sector. As such, the market is expected to expand, driven by innovations that enhance functionality and accessibility in electrophoretic techniques.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Electrophoresis Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Electrophoresis Reagents
  • Gels
  • Buffers
  • Dyes
  • Other
• Electrophoresis Systems
  • Gel Electrophoresis Systems
  • Capillary Electrophoresis Systems
  • Microchip Electrophoresis Systems
• Gel Documentation Systems
• Software

Global Electrophoresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research
  • Proteomics
  • Genomics
  • Drug Discovery
• Diagnostics
  • Hemoglobin Analysis
  • Protein Analysis
  • DNA & RNA Analysis
• Quality Control & Process Validation

Global Electrophoresis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Others

Global Electrophoresis Market Size & CAGR (2024-2031)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harvard Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sebia Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleaver Scientific Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation